At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 30 enrolled
Drug / intervention
Febuxostat +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Subjects With Chronic Stable Angina: A Phase 4 Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study
In Brief
A Phase 4 clinical trial evaluating Febuxostat and Febuxostat placebo for Coronary Artery Disease. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the effect of febuxostat on coronary artery flow in patients with coronary artery disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 2013
Enrollment StartMay 2013
Primary CompletionMar 2015
Study CompletionApr 2015
TodayJul 2026
First PostedJan 9, 2013
Enrollment StartMay 1, 2013
Primary CompletionMar 1, 2015
Study CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 13.5 years ago
Interventions
Febuxostatdrug
Febuxostat capsules
Febuxostat placebodrug
Febuxostat placebo-matching capsules